(71 days)
No
The description focuses on optical and thermistor-based sensing and signal processing, with no mention of AI or ML algorithms for data interpretation or decision-making.
No.
The device is used for monitoring oxygen saturation, hematocrit value, and temperature, which are diagnostic measurements, not therapeutic interventions.
Yes
The device is used for "determining oxygen saturation, hematocrit value and temperature in the venous blood circuit," which is a form of diagnostic measurement of blood values during a medical procedure.
No
The device description explicitly mentions hardware components like sensors, LED sources, a receiver, and thermistors, and the performance studies include testing of hardware and firmware.
Based on the provided information, the Sorin B-Cares is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use clearly states it's for determining oxygen saturation, hematocrit, and temperature in the venous blood circuit during cardiopulmonary bypass. This is a measurement taken directly from the blood flowing through the extracorporeal circuit, not a test performed on a sample of blood outside the body.
- Device Description: The description details how the device uses sensors in contact with the optical window integrated into the venous connectors to monitor blood values. This confirms it's an in-line measurement system.
- Lack of mention of sample handling: There is no mention of collecting blood samples, preparing them, or performing tests on them in a laboratory setting.
IVDs are typically devices used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. The B-Cares is performing real-time measurements on blood within a closed circuit during a medical procedure.
N/A
Intended Use / Indications for Use
The B-Cares is intended for use as a component part of or optional accessory to the Stöckert S5 system (or any compatible system using the S5 firmware versions of 3.0 or greater), during cardiopulmonary bypass for procedures up to six hours. The B-Cares is used exclusively for determining oxygen saturation, hematocrit value and temperature in the venous blood circuit.
Product codes (comma separated list FDA assigned to the subject device)
DRY
Device Description
The Sorin B-Cares described in this 510(k) Premarket Notification is identical to the device that was cleared under K092463 and uses the same in-line sensors cleared under K001388.
When switched on, the Sorin B-Cares progresses from warm-through initialization . self test while resting on the holder. When self test is successful, Sat- (venous saturation) and Hct- (hematocrit) values are displayed. The sensor is then mounted on the disposable connector in the extra-corporal circuit. The B-Cares alerts (alarms or warns) the user if laboratory reference values have not been stored for venous O2 saturation and hematocrit.
The Sorin B-Cares monitors blood values via the sensor head with two LED sources and a receiver in contact with the optical window integrated into the venous connectors. Temperatures are monitored using thermistors in the venous probes. The technology of the Sorin B-Cares is based on the technology of the Dideco Data Master (Sorin Group Italia is the parent company of Sorin Group Deutschland GmbH and was formerly known as Dideco).
The B-Cares is used for determining oxygen saturation, hematocrit, and temperature in the venous blood circuit. Specifications are provided in B-Cares Operating Instructions.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Sorin B-Cares was tested in conjunction with the heart lung machine for safety in accordance with IEC60601-1 (with National Deviations), for electromagnetic compatibility in accordance with IEC60601-1-2, and performance according to a formal prospectively defined functional acceptance test. Testing of the Sorin B-Cares (hardware, firmware, and performance) has demonstrated that the Sorin B-Cares fulfills prospectively defined performance criteria and that the System meets user needs.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.4330 Cardiopulmonary bypass on-line blood gas monitor.
(a)
Identification. A cardiopulmonary bypass on-line blood gas monitor is a device used in conjunction with a blood gas sensor to measure the level of gases in the blood.(b)
Classification. Class II (performance standards).
0
510(k) Summary for the Sorin Group Deutschland GmbHJAN – 6 2011 (per 21 CFR 807.92 and http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/default.htm)
ﺮ: ﺭ
1. SPONSOR/APPLICANT
Sorin Group Deutschland GmbH
Lindberghstrasse 25
80939 Munich
Germany
| Telephone: | 011-49 (0)89 323 01 153 |
|---|---|
| Facsimile: | 011- 49(0)89 323 01 333 |
| Contact: | Renate Goebert |
Date Prepared: January 4, 2010
2. DEVICE NAME
| Proprietary Name: | Sorin B-Care5 |
|---|---|
| Common/Usual Name: | Venous blood gas module for heart lung machine; perfusion monitoring device |
| Classification Name: | Cardiopulmonary bypass, on-line blood gas monitor (21 CFR 870.4330; Product code: DRY) |
3. PREDICATE DEVICE/S
- · Dideco Data Master, K001388
- · Sorin B-Cares (Addition of an Optional Modular Accessory to the Stöckert S5 System), K092463)
4. DEVICE DESCRIPTION
· Physical description
The Sorin B-Cares described in this 510(k) Premarket Notification is identical to the device that was cleared under K092463 and uses the same in-line sensors cleared under K001388.
· How the device functions
When switched on, the Sorin B-Cares progresses from warm-through initialization . self test while resting on the holder. When self test is successful, Sat- (venous
1
saturation) and Hct- (hematocrit) values are displayed. The sensor is then mounted on the disposable connector in the extra-corporal circuit. The B-Cares alerts (alarms or warns) the user if laboratory reference values have not been stored for venous O2 saturation and hematocrit.
- · Scientific concepts that form the basis for the device
The Sorin B-Cares monitors blood values via the sensor head with two LED sources and a receiver in contact with the optical window integrated into the venous connectors. Temperatures are monitored using thermistors in the venous probes. The technology of the Sorin B-Cares is based on the technology of the Dideco Data Master (Sorin Group Italia is the parent company of Sorin Group Deutschland GmbH and was formerly known as Dideco).
· Significant physical and performance characteristics of the device, such as device design, material used, and physical properties
The B-Cares is used for determining oxygen saturation, hematocrit, and temperature in the venous blood circuit. Specifications are provided in B-Cares Operating Instructions.
5. INTENDED USE/INDICATION FOR USE
The B-Cares is intended for use as a component part of or optional accessory to the Stöckert S5 system (or any compatible system using the S5 firmware versions of 3.0 or greater), during cardiopulmonary bypass for procedures up to six hours. The B-Cares is used exclusively for determining oxygen saturation, hematocrit value and temperature in the venous blood circuit.
6. SUMMARY OF TECHNOLOGICAL CHARACTERISTICS COMPARED TO THE PREDICATE DEVICE/S
The technological characteristics of the B-Cares are identical to those reported to the FDA in K092463 and substantially equivalent to those of the Dideco Data Master (K001388). All are firmware-controlled systems using the same in-line connectors with integral sensor probes. All devices read the data external to the blood circulation and display data digitally; all are controlled via touchscreen. Venous saturation and hematocrit values are calibrated to reference (laboratory) values. All provide trending of values and allow the user to program alarm limits. However, the Dideco Data Master can be used independently of a heart lung machine console, whereas the B-Cares cannot be used independently and must be used connected to a Sorin/Stöckert heart lung machine console.
2
Sorin B-Cares and Data Master specifications for the following are identical: saturation resolution, saturation accuracy, hematocrit resolution, and temperature resolution.
There are some minor differences in the operational specifications but all are within clinically relevant ranges. For example, the saturation range for the B-Cares has a wider range (0%-100%) than the Data Master (40%-100%); the B-Cares hematocrit range is 0% to 100% while the Data Master hematocrit range is 15% to 50%; the B-Care, temperature range is 0°C to 50°C while the Data Master temperature range is 10℃ to 45℃. These wider ranges allow the perfusionist to operate and detect the specified parameters at lower and higher levels.
7. SUMMARY OF NON-CLINICAL PERFORMANCE TESTING AS BASIS FOR SUBSTANTIAL EQUIVALENCE
The Sorin B-Cares was tested in conjunction with the heart lung machine for safety in accordance with IEC60601-1 (with National Deviations), for electromagnetic compatibility in accordance with IEC60601-1-2, and performance according to a formal prospectively defined functional acceptance test. Testing of the Sorin B-Cares (hardware, firmware, and performance) has demonstrated that the Sorin B-Cares fulfills prospectively defined performance criteria and that the System meets user needs.
8. SUMMARY OF CLINICAL TESTING AS BASIS FOR SUBSTANTIAL EQUIVALENCE
Formal clinical testing of the Sorin B-Cares has not been performed. Therefore, this section does not apply.
9. SUMMARY OF OTHER INFORMATION
No information other than that described was provided.
· 10. CONCLUSIONS DRAWN FROM NON-CLINICAL AND CLINICAL TESTS
Based on the non-clinical testing provided in this premarket notification, the Sorin B-Cares integrated with the Stöckert SS performs in an identical manner as the B-Cares integrated with the C5, thus demonstrating that there are no differences and that the devices are substantially equivalent and perform in accordance with specifications.
3
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo features a stylized emblem with three curved lines, resembling a human figure, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged in a circular pattern around the emblem. The emblem is black, and the text is also in black.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Sorin Group Deutschland GmbH c/o Ms. Rosina Robinson Medical Device Consultants, Inc. 49 Plain Street North Attleboro, MA 02760
Re: K103168
Trade/Device Name: Sorin B-Cares Regulation Number: 21 CFR 870.4330 Regulation Name: Cardiopulmonary bypass on-line blood gas monitor Regulatory Class: II Product Code: DRY Dated: October 26, 2010 Received: October 27, 2010
Dear Ms. Robinson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
JAN - 6 200
4
Page 2 – Ms. Rosina Robinson
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
inver R. bihner
Image /page/4/Picture/7 description: The image shows a signature on the left side and the words "Br" and "Di" on the right side. The signature appears to be handwritten in black ink. The letters "Br" and "Di" are printed in a simple, sans-serif font. The overall image has a clean and straightforward appearance.
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
INDICATIONS FOR USE STATEMENT
JAN - 6 2011
K103168 510(k) Number (if known):
Device Name:
Sorin B-Cares
Indications for Use:
The B-Cares is intended for use as a component part of or optional accessory to the Stöckert S5 system (or any compatible system using the S5 firmware versions of 3.0 or greater), during cardiopulmonary bypass for procedures up to six hours. The B-Cares is used exclusively for determining oxygen saturation, hematocrit value and temperature in the venous blood circuit.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
uma R. Vachnes
(Division Sign-Off) (Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number K103168